DENTSPLY SIRONA Inc. (XRAY)

NASDAQ • Healthcare

$11.38

-$0.04 (-0.4%)

Market closed

Last close at September 4, 2026 at 20:00 UTC

Day Range$11.2 - $11.53

Avg. Volume (3M)4.1M

Market Cap$2.2B

52 Week Range

$9.4$14.86

Next EarningsIn 62 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$898M100%

Gross Profitminus cost of goods$493M55%

Operating Incomeminus R&D and overhead$82M9%

Net Incomeminus taxes and the rest$37M4%

In plain terms: out of every $100 in revenue, DENTSPLY SIRONA Inc. keeps $4 as net profit.

Fundamentals & Financials

Revenue (TTM)

$3.6B

Net Income (TTM)

-$546M

EPS (TTM)

-$2.74

ROA (TTM)

-10.49%

Current Ratio

1.63

Dividend Yield

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+4.0%Q3 2025$0.52

-17.8%Q4 2025$0.37

-3.6%Q1 2026$0.27

-3.6%Q2 2026$0.27

+49.4%Q3 2026$0.52

Nov 5

in 62 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Beat +49.4%

DENTSPLY SIRONA’s adjusted EPS topped expectations while revenue was in line, alongside a year-over-year sales decline in the second fiscal quarter of 2026 reported August 6, 2026. EPS of $0.52 topped the $0.35 estimate, +49%, while revenue of $898.0 million against a $889.9 million estimate, +0.9%, came in line and still fell 4.1% year over year from $936.0 million. Profitability remained positive, with gross profit of roughly $493.0 million translating to a gross margin of about 55%, and operating income of around $82.0 million for an operating margin near 9%. The company generated about $99.0 million of operating cash flow and repurchased roughly $12.0 million of stock during the quarter. For the next period, consensus calls for EPS of $0.31 on revenue of $865.7 million.

View full earnings history

About DENTSPLY SIRONA Inc.

DENTSPLY SIRONA Inc. develops and sells dental equipment, dental products, and healthcare consumables for clinicians and patients worldwide. Listed on NASDAQ as XRAY, the company operates in healthcare as a maker of medical instruments and supplies, and it generated $3.7 billion in FY2025 revenue.

Name

DENTSPLY SIRONA Inc.

CEO

Daniel T. Scavilla

Website

www.dentsplysirona.com

Industry

Healthcare

Year Founded

1877

Employees

14,000

Today's Snapshot

AI-generated

XRAY closed slightly lower at 11.38, while its sector was weaker. DENTSPLY SIRONA returned to profit in its second quarter, though sales fell 4.1% from a year earlier.

Trading Volume

Below 10d avg (3.5M)

2.5M

vs S&P 500 Today

Inline with Market

-0.02%

Updated: September 4, 2026 at 20:10 UTC

Technical Indicators

1 Buy3 Neutral4 Sell

XRAY carries a sell indication despite some short-term strength, as the stock trades near 11.38 while longer-dated moving averages sit above the price and imply medium-to-longer-term resistance. Momentum readings are mixed and MACD is flat, while ADX signals only moderate trend strength, so there is limited conviction behind recent moves. Volatility is moderate with an ATR near 0.50, and OBV shows buying but not enough to flip the overall bias given the prevalence of sell signals among the medium and long averages. Technical takeaway: Sell.

All signals